US › Healthcare

Apnimed, Inc. Common Stock (APMD)

US · Healthcare · Biotechnology

$25.71+2.84%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$84.8M
Net profit
$70.4M
Net margin
83.0%

Key statistics

Market cap
$995.6M
P/E
8.2
Forward P/E
0.0
P/B
3.69
Book value
$-53.95
EPS (TTM)
$3.05
52-week high
$29.15
52-week low
$16.00
50-day MA
$25.00
200-day MA
$25.00

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Apnimed, Inc. Common Stock — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.